Abstract Background: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the…
Abstract Background: Preclinical and human studies suggest that adolescent cannabis use may be associated with worse cognitive outcomes than adult…
Abstract The trend toward cannabis legalization in the United States over the past two decades has unsurprisingly been accompanied by…
Abstract Physiological brain aging is characterized by gradual, substantial changes in cognitive ability, accompanied by chronic activation of the neural…
Abstract Background: Use of cannabidiol (CBD), the primary non-psychoactive compound found in cannabis, has recently risen dramatically, while relatively little…
Abstract Background: Cannabidiol (CBD) is being investigated as a potential treatment for several medical indications, many of which are characterised…
Abstract Rationale: Prolonged use of cannabis, the most widely used illicit drug worldwide, has been consistently associated with impairment in…
Abstract Background: Δ9-Tetrahydrocannabinol (THC, a CB1 receptor agonist) and Cannabidiol (CBD, a non-competitive antagonist of endogenous CB1 and CB2 ligands)…
Abstract Rationale: While cannabis-based medicinal products have been shown to be effective for numerous neurological and psychiatric disorders, the evidence…
Abstract Oleoylethanolamide is an endogenous NAE that modulates ethanol-seeking behavior and ethanol-induced neuroinflammation. In the present study we further analyze…